Pages

Tuesday, March 27, 2012

Pioneering New Science Nucleosomics Advances Blood Based Diagnostics for Cancer

VolitionRX now calling for key partners and collaborators to bolster large scale clinical validation LONDON, March 27, 2012 /PRNewswire/ -- The ability to diagnose disease early has long been a goal in the medical arena. VolitionRX (VNRX.OB), a life sciences company, is pioneering scientific research into simple, cost-effective tools capable of diagnosing the early presence of disease via a blood test. (Photo: http://photos.prnewswire.com/prnh/20120327/NY77344 ) VolitionRX is devel...continued
 

No comments:

Post a Comment